Changeflow GovPing Healthcare & Life Sciences Dental Composite Material - Kulzer GmbH - US126...
Routine Notice Added Final

Dental Composite Material - Kulzer GmbH - US12605307B2

Favicon for changeflow.com USPTO Patent Grants - Pharma (A61K)
Published
Detected
Email

Summary

The USPTO granted patent US12605307B2 to Kulzer GmbH on April 21, 2026, covering a polymerisable dental composite material comprising 40-90% inorganic filler, 10-60% urethane (alkyl) acrylate, 0.01-15% functional monomers, and 0.01-10% initiator/stabiliser. The patent, originating from application 17773261 (filed October 29, 2020), contains 8 claims and names inventors Andreas Utterodt, Christoph Meier, Nelli Schoenhof, Jutta Schneider, Kurt Reischl, Raif Kocoglu, and Michael Eck. The patent covers both the unpolymerised composite and the polymerised material for direct or indirect dental restorations.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Grants - Pharma (A61K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 22 changes logged to date.

What changed

The USPTO granted patent US12605307B2 to Kulzer GmbH on April 21, 2026. The patent covers a polymerisable dental composite material with a specific formulation: 40-90% inorganic filler (dental glass ± amorphous metal oxide), 10-60% urethane (alkyl) acrylate, 0.01-15% non-urethane functional monomers, and 0.01-10% initiators/stabilisers/pigments. CPC classifications include A61K 6/893, A61K 6/887, and C08L 33/08/10.

For dental material manufacturers and dental laboratories, this grant confers exclusive rights to Kulzer GmbH for the claimed composite formulation in the United States. Competitors developing similar urethane-acrylate-based dental composites should conduct freedom-to-operate analyses to assess potential infringement exposure. Dental product companies licensing or acquiring similar technology should verify that the licensed formulation does not overlap with the protected composition-of-matter claims.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Dental composite material

Grant US12605307B2 Kind: B2 Apr 21, 2026

Assignee

Kulzer GmbH

Inventors

Andreas Utterodt, Christoph Meier, Nelli Schoenhof, Jutta Schneider, Kurt Reischl, Raif Kocoglu, Michael Eck

Abstract

The invention relates to a polymerisable dental composite material comprising
(i) 40 to 90% by weight of an inorganic filler component comprising at least one dental glass, as well as optionally at least one an amorphous metal oxide,(ii) 10 to 60% by weight of at least one urethane (alkyl) acrylate of the idealised formula I,(iii) 0.01 to 15% by weight of at least one di-, tri-, tetra- or multi-functional monomer not being a urethane (alkyl) acrylate,(iv) 0.01 to 10% by weight of at least one initiator, of an initiator system, as well as optionally of at least one stabiliser, and optionally of at least one pigment, the total composition of the composite material amounting to 100% by weight, as well as to a polymerised composite material for producing direct dental restorations or indirect dental restorations.

CPC Classifications

A61K 6/893 A61K 6/887 A61K 6/76-79 C08L 33/08 C08L 33/10

Filing Date

2020-10-29

Application No.

17773261

Claims

8

View original document →

Get daily alerts for USPTO Patent Grants - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 21st, 2026
Instrument
Notice
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12605307B2

Who this affects

Applies to
Manufacturers Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent grant Dental materials IP IP rights issuance
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when USPTO Patent Grants - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!